Safety and efficacy of extended bevacizumab (BEV) therapy in elderly (> 70 years) patients (pts) treated for newly diagnosed ovarian cancer (OC) in the international ROSiA study - Selle, F; Colombo, N; Korach, J (J Clin Oncol, 2016)
(suppl; abstr 5535)